Journal article

Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar

J Landier, L Kajeechiwa, MM Thwin, DM Parker, V Chaumeau, J Wiladphaingern, M Imwong, O Miotto, K Patumrat, J Duanguppama, D Cerqueira, B Malleret, L Rénia, S Nosten, L Von Seidlein, C Ling, S Proux, V Corbel, JA Simpson, AM Dondorp Show all

Wellcome Open Research | Published : 2017

Abstract

Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater Mekong Sub-region (GMS). Eliminating falciparum malaria in the GMS while drugs still retain enough efficacy could prevent global spread of antimalarial resistance. Eliminating malaria rapidly requires targeting the reservoir of asymptomatic parasite carriers. This pilot trial aimed to evaluate the acceptability, safety, feasibility and effectiveness of mass-drug administration (MDA) in reducing malaria in four villages in Eastern Myanmar. Methods: Villages with ≥30% malaria prevalence were selected. Long-lasting insecticidal bednets (LLINs) and access to malaria early diagnosis and treatment (..

View full abstract

University of Melbourne Researchers